Portolan Capital Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $274K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $34.2K | Sell |
|
|||||
|
2024
Q1 | $2.96M | Buy |
|
|||||
|
2023
Q4 | $3.6M | Buy |
|
|||||
|
2023
Q3 | $1.94M | Sell |
|
|||||
|
2023
Q2 | $4.3M | Sell |
|
|||||
|
2023
Q1 | $4.38M | Sell |
|
|||||
|
2022
Q4 | $2.92M | Sell |
|
|||||
|
2022
Q3 | $3.44M | Sell |
|
|||||
|
2022
Q2 | $8.83M | Sell |
|
|||||
|
2022
Q1 | $15.7M | Sell |
|
|||||
|
2021
Q4 | $17.9M | Buy |
|
|||||
|
2021
Q3 | $16.5M | Buy |
|
|||||
|
2021
Q2 | $15.1M | Buy |
|
|||||
|
2021
Q1 | $8.79M | Buy |
|
|||||
|
2020
Q4 | $5.75M | Buy |
|
|||||
|
2020
Q3 | $2.95M | Buy |
|
|||||
|
2020
Q2 | $1.8M | Buy |
|